Mesothelioma kills primarily by suffocating and compressing vital organs from the outside in. Unlike most cancers that form a discrete tumor and then spread through the bloodstream, mesothelioma grows as a thick rind of tissue that encases the lung, lines the abdominal cavity, or in rare cases surrounds the heart. The disease progression is relentless and largely local, and the final cause of death is usually respiratory failure, though the path there involves a cascade of complications that erode the body’s ability to breathe, eat, move, and fight infection.
How Asbestos Starts the Process
Mesothelioma begins with microscopic asbestos fibers lodging in the body’s internal linings. When inhaled, these needle-like fibers pass through the walls of the lung’s air sacs and enter the tissue beneath. From there, they migrate along fluid flows and lymphatic channels, eventually reaching the pleura, the thin double-layered membrane that wraps each lung and lines the inside of the chest wall. Some fibers travel further, entering the bloodstream and distributing to other parts of the body.1PubMed Central. Translocation pathways for inhaled asbestos fibers
Once embedded in the pleura, asbestos fibers are essentially permanent. The body tries to remove them: immune cells called macrophages swarm the fibers and attempt to engulf them, but the fibers are too long and rigid to be broken down. This frustrated cleanup effort triggers a chain reaction of cell damage. The macrophages and the mesothelial cells lining the pleura release reactive molecules that damage DNA in surrounding cells. The process also releases a protein called HMGB1, which drives chronic inflammation in the tissue around the asbestos deposits.2PubMed Central. Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy Over decades, this relentless cycle of inflammation and DNA damage causes some mesothelial cells to undergo malignant transformation. Most cells exposed to asbestos die, but the survivors accumulate genetic mutations that eventually allow them to grow without restraint.3PubMed Central. Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review
This latency period, typically 20 to 50 years between exposure and diagnosis, is one of the cruelest features of the disease. By the time symptoms appear, the cancer has usually been growing silently for years.
The Pleural Rind and the Drowning Lung
About three-quarters of mesothelioma cases start in the pleura, and the way the disease kills in this location is distinctive. Instead of forming a ball-shaped mass like most solid tumors, pleural mesothelioma spreads as a sheet. It coats the pleural surfaces in a thick, irregular rind that progressively encases the lung. Think of the lung as a balloon inside a rigid box: the tumor essentially wraps the balloon in concrete.
As this rind thickens, two things happen simultaneously. First, the tumor irritates the pleura and causes it to produce large volumes of fluid. A healthy person has only a few teaspoons of pleural fluid lubricating the space between the lung and chest wall. In mesothelioma, liters of fluid can accumulate, compressing the lung from the outside and making it progressively harder to expand. This is one of the earliest and most common symptoms: breathlessness that worsens over weeks or months.
Research has shown that this pleural fluid is not just a passive bystander. In laboratory studies, fluid drawn from mesothelioma patients consistently stimulated cancer cells to grow roughly twice as fast as they would otherwise, and also drove them to migrate more aggressively.4Wiley Online Library / Respirology. Malignant pleural fluid from mesothelioma has potent biological activities The fluid the tumor produces feeds its own growth, creating a vicious cycle.
Second, as the tumor invades deeper, it physically traps the lung. The visceral pleura (the layer directly on the lung surface) becomes so thickened and stiff that the lung can no longer expand, even if the fluid is drained. Clinicians call this “trapped lung” or “lung entrapment,” and it represents a mechanical point of no return: the lung simply cannot inflate anymore because its outer covering has been replaced by armor-like tumor tissue.5Chest. Avoid the Trap: Nonexpanding Lung One published case report illustrates this progression starkly: a patient returned with worsening breathlessness, and imaging revealed not only a large trapped fluid collection but new tumor masses throughout the right chest and fluid accumulating in the abdomen as well.6American Journal of Respiratory and Critical Care Medicine. Delayed Diagnosis of Malignant Pleural Mesothelioma Presenting as Progressive Respiratory Failure: A Case Report
Invasion Into the Chest Wall and Beyond
Mesothelioma does not stay on the surface forever. As it grows, the tumor rind infiltrates the structures adjacent to the pleura: the chest wall muscles, the ribs, the diaphragm, and the tissue surrounding the heart and major blood vessels. This invasion is direct, not through the bloodstream. The cancer literally grows into whatever it touches.
Diaphragm invasion is particularly consequential because the diaphragm is the main breathing muscle. When tumor encases or infiltrates the diaphragm, it can no longer contract properly, and the patient loses another critical mechanism for expanding the lungs. Imaging studies have documented that detecting this invasion early is difficult, though MRI is better than CT at revealing it.7American Journal of Roentgenology (AJR). Staging of malignant pleural mesothelioma: comparison of CT and MR imaging
When tumor grows into the mediastinum, the central compartment of the chest, it can compress or obstruct major blood vessels. In one documented case, a mesothelioma patient developed superior vena cava syndrome: the tumor compressed the main vein draining the head and arms, causing facial swelling, distended neck veins, and difficulty breathing.8Journal of Cancer Research and Therapeutics. Mesothelioma with superior vena cava obstruction in young female following short latency of asbestos exposure Compression of the esophagus can make swallowing difficult. Compression of the heart itself can restrict its ability to fill and pump blood.
What Happens in Peritoneal Mesothelioma
When mesothelioma develops in the abdominal lining instead of the chest, the killing mechanism shifts. The peritoneum lines the abdominal cavity and covers the intestines, liver, and other organs. Peritoneal mesothelioma coats these surfaces with tumor, and the consequences are different from the pleural form but equally devastating.
The most dangerous local complication is bowel obstruction. As the tumor studds the omentum (the fatty apron that hangs in front of the intestines), it creates points where the bowel kinks or becomes pinched. Case reports describe tumor invading directly through the muscular wall of the small intestine and into its inner lining, physically blocking the passage of food.9Radiology Case Reports. Diffuse malignant peritoneal mesothelioma presenting as small bowel obstruction Imaging typically shows diffuse masses throughout the peritoneum that converge on the omentum, creating a focal point for obstruction.10PubMed Central. Primary Peritoneal Mesothelioma Resulting in Small Bowel Obstruction: A Case Report and Review of Literature Patients who cannot eat or absorb nutrition through their gut deteriorate rapidly.
The other major problem is malignant ascites: massive fluid accumulation in the abdomen, analogous to the pleural effusion in chest-based disease. One case documented ascites from peritoneal spread of a right-sided pleural mesothelioma, meaning the disease had crossed from the chest into the abdomen.11Surgical Laparoscopy, Endoscopy & Percutaneous Techniques. Successful Palliation of Malignant Ascites From Peritoneal Mesothelioma by Laparoscopic Intraperitoneal Hyperthermic Chemotherapy Abdominal distension from liters of fluid compresses the diaphragm from below, adding another layer to the breathing difficulty that often already exists from pleural disease.
Muscle Wasting, Blood Clots, and Systemic Decline
While the local effects of tumor compression and fluid accumulation dominate the clinical picture, mesothelioma also weakens the body through systemic processes that accelerate death. Cancer-related muscle wasting, called sarcopenia, is strikingly common. One study of pleural mesothelioma patients found that about a third already had significant muscle loss at diagnosis, and over 60% lost further muscle mass during chemotherapy. Severe muscle loss was independently linked to much shorter survival.12PubMed Central / Elsevier. The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma This wasting is not simply from poor appetite; the cancer releases inflammatory signals that break down muscle tissue throughout the body, contributing to profound weakness that can leave patients bedbound.
Blood clots represent another systemic danger. Many cancers increase clotting risk, and mesothelioma is no exception. In a study of peritoneal mesothelioma patients, roughly one in five developed a blood clot, with pulmonary emboli accounting for the majority of events.13PubMed. Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden Risk In pleural mesothelioma, one study identified clotting events in about 8% of patients, including pulmonary embolisms, deep vein thrombosis, and heart attacks.14PubMed. Thromboembolic Events in Malignant Pleural Mesothelioma A large pulmonary embolism in someone whose lungs are already compromised by tumor and fluid can be immediately fatal.
In rare cases, mesothelioma triggers paraneoplastic syndromes, in which the immune system attacks healthy tissues in response to the cancer. One published case described a patient whose mesothelioma caused an autoimmune attack on the brainstem, leading to an inability to look up or down, a condition called vertical gaze palsy, driven by anti-Ma2 antibodies generated by the cancer.15Thorax / BMJ. Paraneoplastic phenomenon in mesothelioma These neurological complications are uncommon but illustrate how mesothelioma’s reach extends beyond the tissues it physically invades.
Where Mesothelioma Spreads in Late Stages
Mesothelioma was once considered a purely local disease, but modern imaging and longer patient survival have revealed that distant metastases are more common than previously thought. A study examining metastatic patterns in the modern era found that about one in five patients developed bone metastases, while about a quarter had peritoneal and omental spread. Liver metastases were the most common visceral site. Roughly one in ten cases showed diffuse miliary-pattern lung deposits, tiny seed-like spots scattered throughout the lung tissue, and about 3% developed brain metastases.16Journal of Clinical Oncology. Patterns of metastases in malignant pleural mesothelioma in the modern era: Redefining the spread of an old disease.
These distant deposits can cause their own complications: bone pain and fractures, liver failure, seizures. But even when metastases are present, the primary cause of death is usually still what is happening in the chest. The local disease kills faster than the metastases do, because the lungs and heart are less tolerant of compression than most other organs.
Pericardial Mesothelioma and the Heart
A small number of mesothelioma cases arise in the pericardium, the sac surrounding the heart. This is the rarest and often the most rapidly lethal form. The pericardium has very little room to accommodate extra tissue or fluid. Even a thin layer of tumor can restrict the heart’s ability to fill between beats, a condition called cardiac tamponade, or gradually stiffen the pericardium so much that the heart is essentially squeezed, known as constrictive pericarditis. Both conditions cause dangerously low blood pressure, organ failure, and death if untreated.17Advances in Anatomic Pathology. Pericardial Mesotheliomas Because symptoms are nonspecific early on, pericardial mesothelioma is frequently diagnosed only at autopsy.
Why Standard Treatments Often Fail
One reason mesothelioma is so lethal is that it resists the treatments that work well against many other cancers. Genome-wide analysis of mesothelioma tumors has shown that the cancer overexpresses genes involved in repairing chemotherapy-induced and radiation-induced DNA damage. In plain terms, when drugs or radiation break the cancer’s DNA, the cancer has unusually efficient repair machinery that stitches the breaks back together before the cell dies. The same research found that genes governing immune cell infiltration were turned down, which may help explain why the cancer also resists some immunotherapy approaches.18PubMed. Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets
Surgery faces its own limitations. Because mesothelioma grows as a sheet rather than a discrete lump, removing all of it surgically is extremely difficult. Even radical procedures that strip the entire pleura or remove the lung on the affected side often leave microscopic residual disease. Radiation after surgery is sometimes used to clean up remaining cells, but the anatomy of the chest makes this risky. One study documented cases of fatal radiation pneumonitis, severe and fatal lung inflammation, in patients who received high-intensity radiation to the remaining lung after surgery. The patients who died had received radiation to a slightly larger volume of lung tissue than those who survived, highlighting how thin the margin of safety can be.19PubMed Central / Elsevier. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma
Pain and the Terminal Phase
As the disease advances, pain becomes one of the most significant burdens. Pain in mesothelioma has multiple sources: the tumor grows directly into the chest wall and invades between the ribs, encasing the intercostal nerves that run along the underside of each rib. This creates neuropathic pain that is difficult to treat with standard painkillers because it originates from nerve damage rather than tissue inflammation.20PubMed Central. Pain management in patients with malignant mesothelioma: challenges and solutions Some patients also develop pain from prior surgical incisions, known as post-thoracotomy syndrome, or from nerve damage caused by chemotherapy.
In the final weeks and months, breathlessness typically becomes the dominant symptom. When both fluid accumulation and lung entrapment are advanced, even supplemental oxygen provides limited relief because the problem is mechanical: the lung simply has no room to expand. Anxiety and depression are common, driven both by the sensation of air hunger and by awareness of the prognosis. Palliative care specialists working with mesothelioma patients have emphasized that managing these psychological dimensions is as important as controlling physical symptoms, and that advance care planning with both the patient and their family is a critical part of end-of-life care.21PubMed. Palliative care for the patient with mesothelioma
The immediate cause of death varies from patient to patient. For some, it is progressive respiratory failure as the lungs lose the ability to exchange oxygen and carbon dioxide. For others, it is a pneumonia that takes hold in a lung too compressed and damaged to clear infection. Cardiac complications, pulmonary embolism, bowel obstruction in peritoneal disease, or organ failure from widespread tumor can each be the final event. What these pathways share is a common upstream cause: a cancer that grows not as a discrete mass but as a suffocating encasement, slowly crushing the organs it surrounds until one system or another gives out.
How Mesothelioma Differs From Lung Cancer
People often conflate mesothelioma with lung cancer because both involve the chest and both are linked to inhaled exposures. But the two diseases behave very differently, and the distinction matters for understanding how mesothelioma kills. Lung cancer typically starts inside the lung tissue itself, as a nodule or mass that grows outward, eventually blocking airways or eroding blood vessels. Mesothelioma starts on the surface, outside the lung, and grows inward. Lung cancer commonly spreads early and widely to distant organs; mesothelioma tends to do most of its damage locally, through compression and invasion of neighboring structures, even though late-stage metastases do occur.
This growth pattern is why mesothelioma patients sometimes describe feeling as if they are being slowly constricted. The tumor does not create a blockage in a single airway; it encases the entire lung in an ever-tightening shell. Treatments designed for lung cancer, which target a discrete mass and its metastases, are not well suited to a disease that carpets an entire body cavity. This mismatch between the disease’s biology and the tools available to fight it is a fundamental part of why mesothelioma remains so difficult to survive.